Results for tag: "Nanobodies"

Nanobodies are a type of nanomedicine that are used to target and treat diseases at the molecular level. They are small, single-domain antibodies that are derived from llamas, camels, and other animals. They are able to bind to specific targets with high affinity and specificity, making them ideal for use in drug delivery and diagnostics. Nanobodies have been used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. They have also been used to develop targeted therapies for a range of conditions, including cardiovascular disease, diabetes, and neurological disorders. Nanobodies are increasingly being used in the development of personalized medicine, as they can be tailored to the individual patient's needs. They are also being used in the development of novel drug delivery systems, as they can be used to target specific cells or tissues. Companies in the Nanobodies market include Ablynx, Abpro, Abpro Biotherapeutics, Abpro Technologies, Abpro Therapeutics, Abpro Diagnostics, Abpro Pharma, Abpro Biopharma, Abpro Biotech, Abpro Diagnostics, and Abpro Technologies. Show Less Read more